Who
Gregory D. Gorgas
Pres, CEO, CFO, Treas & Secr
Company insider
Files Form 4 as: Pres, CEO, CFO, Treas & Secr, Artelo Biosciences; Senior VP, Commercial, Savara.
In numbers
- Trades disclosed
- 46
- Buys
- 11
- Sells
- 0
- Bought
- $61K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 21 Jul 2011
- Last trade
- 29 Jan 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jan 2026filed 2 Feb 2026 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —154,713 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —154,713 at $0.00 | filing |
| 28 Oct 2025filed 30 Oct 2025 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code C | $335.5M9,586 at $35,000.00 | filing |
| 28 Oct 2025filed 30 Oct 2025 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code C | —17,952 | filing |
| 28 Oct 2025filed 30 Oct 2025 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code C | — | filing |
| 28 Oct 2025filed 30 Oct 2025 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code C | — | filing |
| 2 Jul 2025filed 7 Jul 2025 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,393 at $0.00 | filing |
| 2 Jul 2025filed 7 Jul 2025 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code P | — | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,000 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —55,634 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —38,340 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —90,334 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —85,000 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,634 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —38,340 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,334 | filing |
| 28 Feb 2024filed 1 Mar 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 | filing |
| 5 Jan 2024filed 8 Jan 2024 | ARTL Artelo Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,000 at $0.00 | filing |
News
Artelo Biosciences, Inc. (NASDAQ:ARTL) Stock Short Interest Climbs 104.7%ARTL · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Gregory D. Gorgas; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.